Clinical Trial Update: Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy, safety, and radiographic progression of brodalumab in psoriatic arthritis was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• SILIQ (brodalumab)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriatic Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2017-05-19